“antibiotics” Archives

Entry Author Date Location
Optimer Pockets $68M Upfront From Astellas For Rights to Antibiotic in Europe 02/07/11 San Diego
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics 01/11/11 Boston
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Genentech Licenses AMRI Compounds 01/04/11 Seattle
Avalon Funds Antibiotics Development at New Startup, RQx Pharmaceuticals 12/14/10 San Diego
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug 11/30/10 San Diego
Glaxo Buys $129M in Theravance Stock 11/29/10 San Francisco
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop 11/10/10 San Diego
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
AvidBiotics Creates Novel Proteins that Kill Bacteria on the Farm, in the Lab, in the Body 09/21/10 San Francisco
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference 09/15/10 Boston
Why We Think Investing in Antibiotics Makes Sense 09/14/10 San Francisco
Trius Ends First Day Trading at $5 a Share 08/03/10 San Diego
Trius Chops IPO Price, Offers More Shares 08/02/10 San Diego
Optimer Seeks EU Approval 07/29/10 San Diego
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
Trius IPO Plans Back on Track 07/15/10 San Diego
$4.5M for Excelimmune 07/07/10 Boston
Trius Gets FDA Clarity 06/16/10 San Diego
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News 06/04/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
Trius Gets $29.5M Defense Contract 05/20/10 San Diego
Clinical Data Seeks to Challenge Lilly, Pfizer in Antidepressant Market 05/11/10 Boston
Optimer Hires New CEO 05/06/10 San Diego
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer 04/20/10 San Diego
Frazier, Arch Join $56M Antibiotic Deal 04/07/10 Seattle
Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company 03/23/10 Boston
Trius Puts the Brakes on IPO Plan, While It Adjusts to New FDA Clinical Guidelines 03/05/10 San Diego
Optimer Nets $51.5M 03/01/10 San Diego
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy 02/16/10 Boston
Page 4 of 6 « previous page · next page »